Tumor Dormancy, Angiogenesis and Metronomic Chemotherapy
Gianfranco Natale et al, 2017 CrossRef
Moving Forward with Metronomic Chemotherapy: Meeting Report of the 2nd International Workshop on Metronomic and Anti-Angiogenic Chemotherapy in Paediatric Oncology
Eddy Pasquier et al, 2011, Translational Oncology CrossRef
Novel isatin derivatives of podophyllotoxin: synthesis and cytotoxic evaluation against human leukaemia cancer cells as potent anti-MDR agents
Lei Zhang et al, 2015, RSC Adv. CrossRef
Etoposide-Loaded Poly(Lactic-co-Glycolic Acid) Intravitreal Implants: In Vitro and In Vivo Evaluation
Ana Gabriela Reis Solano et al, 2018, AAPS PharmSciTech CrossRef
Does metronomic chemotherapy induce tumor angiogenic dormancy? A review of available preclinical and clinical data
Gianfranco Natale et al, 2018, Cancer Letters CrossRef
Nano-targeted induction of dual ferroptotic mechanisms eradicates high-risk neuroblastoma.
Behrouz Hassannia et al, 2018, J Clin Invest CrossRef
The addition of metronomic chemotherapy does not improve outcome for canine splenic haemangiosarcoma
C. K. Alexander et al, 2018, J Small Anim Pract CrossRef
Tumor endothelial cells as a potential target of metronomic chemotherapy
Ji Yoon Kim et al, 2019, Arch. Pharm. Res. CrossRef
Successful treatment of metastatic cerebral recurrence of pleuropulmonary blastoma
Yoshiko Nakano et al, 2019, Pediatr Blood Cancer CrossRef
Mechanisms of Action of Low-Dose Metronomic Chemotherapy
Ella Fremder et al, 2014 CrossRef
Regulation of inflammation in cancer by eicosanoids
Emily R. Greene et al, 2011, Prostaglandins & Other Lipid Mediators CrossRef
Low-dosage metronomic chemotherapy and angiogenesis: topoisomerase inhibitors irinotecan and mitoxantrone stimulate VEGF-A-mediated angiogenesis
PER ALBERTSSON et al, 2012 CrossRef
Treatment for recurrent medulloblastoma with intrathecal liposomal cytarabine and systemic metronomic combination therapy
Randi Nygaard et al, 2012, Anti-Cancer Drugs CrossRef
Antiangiogenic metronomic therapy for children with recurrent embryonal brain tumors
Andreas Peyrl et al, 2012, Pediatr. Blood Cancer CrossRef
Excellent Response to Oral Etoposide in HER2-Positive Metastatic Breast Cancer (MBC)
Manikandan Dhanushkodi et al, 2019, Indian J Gynecol Oncolog CrossRef
A phase II trial of a multi-agent oral antiangiogenic (metronomic) regimen in children with recurrent or progressive cancer
Nathan J. Robison et al, 2014, Pediatr Blood Cancer CrossRef
High Throughput Screening of Natural Products for Anti-mitotic Effects in MDA-MB-231 Human Breast Carcinoma Cells
E. Mazzio et al, 2014, Phytother. Res. CrossRef
Initial Experience With Gallium-68 DOTA-Octreotate PET/CT and Peptide Receptor Radionuclide Therapy for Pediatric Patients With Refractory Metastatic Neuroblastoma
Grace Kong et al, 2016, Journal of Pediatric Hematology/Oncology CrossRef
Novel Etoposide Analogue Modulates Expression of Angiogenesis Associated microRNAs and Regulates Cell Proliferation by Targeting STAT3 in Breast Cancer
Chatla Srinivas et al, 2015, PLoS ONE CrossRef
Chemotherapy and Hormone Refractory Advanced Breast Cancer: Excellent Response to Oral Etoposide
Manikandan Dhanushkodi et al, 2019, Indian J Gynecol Oncolog CrossRef
Inhibition of polo-like kinase 4 (PLK4): a new therapeutic option for rhabdoid tumors and pediatric medulloblastoma.
Simone Treiger Sredni et al, 2017, Oncotarget CrossRef
Chimiothérapie métronomique en 2011 : actualités et perspectives
Zineb Benbrahim et al, 2011, Bulletin du Cancer CrossRef
Sequential Treatment of Bioresponsive Nanoparticles Elicits Antiangiogenesis and Apoptosis and Synergizes with a CD40 Agonist for Antitumor Immunity
Xiang Ling et al, 2020, ACS Nano CrossRef
Cytoreductive Chemotherapy Improves the Biodistribution of Antibodies Directed against Tumor Necrosis in Murine Solid Tumor Models
Julie K. Jang et al, 2013, Mol Cancer Ther CrossRef
Enhanced Antitumor Efficacy of Low-Dose Etoposide with Oncolytic Herpes Simplex Virus in Human Glioblastoma Stem Cell Xenografts
Tooba A. Cheema et al, 2011, Clin Cancer Res CrossRef
Formalizing an Integrative, Multidisciplinary Cancer Therapy Discovery Workflow
Mary F. McGuire et al, 2013, Cancer Res CrossRef
GT198 Is a Target of Oncology Drugs and Anticancer Herbs
Junfeng Pang et al, 2021, Front. Oral. Health CrossRef
Vitamin D3/phospholipid complex decorated caseinate nanomicelles for targeted delivery of synergistic combination therapy in breast cancer
Mona M. Agwa et al, 2021, International Journal of Pharmaceutics CrossRef
Innovative therapy concepts for pediatric brain tumors
Amedeo A. Azizi et al, 2021, memo CrossRef
Antiangiogenic Compound Axitinib Demonstrates Low Toxicity and Antitumoral Effects against Medulloblastoma
Marina Pagnuzzi-Boncompagni et al, 2021, Cancers CrossRef
Relapsed Medulloblastoma in Pre-Irradiated Patients: Current Practice for Diagnostics and Treatment
Rebecca M. Hill et al, 2021, Cancers CrossRef
IGF2BP2 Induces U251 Glioblastoma Cell Chemoresistance by Inhibiting FOXO1-Mediated PID1 Expression Through Stabilizing lncRNA DANCR.
Junfei Han et al, 2021, Front Cell Dev Biol CrossRef
PA Imaging: A promising tool for targeted therapeutic implications in Cancer
Samudyata C. Prabhuswamimath, 2022 CrossRef
Novel Pharmacological Treatment Options in Pediatric Glioblastoma—A Systematic Review
Johanna Wyss et al, 2022, Cancers CrossRef
Improved Long-Term Survival of Patients with Recurrent Medulloblastoma Treated with a “MEMMAT-like” Metronomic Antiangiogenic Approach
Irene Slavc et al, 2022, Cancers CrossRef
A liposomal etoposide with a sustained drug release effectively alleviated the therapy-related leukemia
Yan Xiong et al, 2023, International Journal of Pharmaceutics CrossRef
Sustained Survival Benefit in Recurrent Medulloblastoma by a Metronomic Antiangiogenic Regimen
Andreas Peyrl et al, 2023, JAMA Oncol CrossRef
Nanocrystal-Loaded Lipid Carriers for Improved Oral Absorption and Anticancer Efficacy of Etoposide: Formulation Development, Transport Mechanism, In Vitro and In Vivo Evaluation
Yue Wang et al, 2024, Mol. Pharmaceutics CrossRef